Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Norgine BV

www.norgine.com

Latest From Norgine BV

Deal Watch: Genentech Sees Bicycle As Route To Novel Targeted Cancer Immunotherapies

Genentech pays $30m up front in a collaboration with Bicycle in a deal that could bring the UK biotech roughly $1.7bn in total. Also, deals involving Nimble, Seattle Genetics, Five Prime, Fresenius, Vifor, Yuhan, Imnewrun, Paratek, Almirall, MBD, AzothBio, Norgine, Faes, Aspen Pharmacare, Swixx.

Deals Business Strategies

No-Deal Brexit 'Very Bad' For Business And Patients

Peter Martin, COO of Norgine, is concerned about the ‘mood music’ in the political environment in the UK, and warns about the risks of the UK leaving the EU without a deal in place.

Brexit Trade

From Stockpiling To Product Launches: Norgine Executive Shares Brexit Fears

A European firm with significant operations in the UK, Norgine has invested considerable resources in preparing for Brexit. With less than three weeks to go before the UK is scheduled to leave the EU, chief operating officer Peter Martin is very concerned about the risks of a no-deal Brexit, and the lack of clarity on what will happen next.

Brexit Trade

Germany’s OTC Market in 2018: Online Sees Double-Digit Growth, Bionorica’s Canephron Uno Tops New Launches

Germany's online channel continued to expand to expand in 2018, with OTC product sales via mail-order pharmacy growing almost 10-times faster than through bricks-and-mortar pharmacy. Meanwhile, GSK's Voltaren brand was top-seller through both channels and Bionorica's Canephron Uno was the best-selling launch during the 12 months. 

Health OTC Drugs
See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Gastrointestinal
  • Hepatic (Liver)
  • Neurology, Nervous System
  • Alias(es)
  • Norgine International Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Parent & Subsidiaries
  • Norgine BV
  • Senior Management
  • Peter Stein, Chmn. & CEO
    Christopher Bath, CFO
    Paul Pay, Chief Bus. Dev. Officer
    Alastair Benbow, Chief Dev. & Medical Officer
    Kenneth Scrimgeour, Chief Commercial Officer
  • Contact Info
  • Norgine BV
    Phone: (31) 1895 826 600
    Hogehilwig 7
    Amsterdam, 1101 CA
    Netherlands
UsernamePublicRestriction

Register